This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Europe
Life Science Fundraising & Investment
24 March 2026 - Pre-day forums (Life Science Companies only), Feira Internacional de Lisboa25-26 March 2026 - Main days, Lisbon Congress Centre, Lisbon, Portugal

December 2025

Why is LSX Europe moving to Lisbon?

Lisbon is quickly emerging as a powerhouse for biotech innovation, making it the perfect setting for LSX World Congress. Discover why Lisbon is the ideal home for this year’s event.

#LSXEurope

As Europe’s innovation landscape continues to expand, Lisbon has emerged as one of the continent’s most dynamic, strategically positioned, and future-focused destinations for biotech. Hosting LSX World Congress in Lisbon is more than a logistical choice, it’s a strategic alignment with a city and a country undergoing a powerful transformation in research, entrepreneurship, and global connectivity.

A Global Gateway for Biotech Partnerships

Lisbon’s location offers a unique advantage for a conference centred on international deal-making and scientific collaboration. Positioned at the intersection of Europe, the Americas, and Africa, the city seamlessly links multiple markets. This makes it easy for attendees to engage with partners, investors, and innovators from an exceptionally broad geographic range. For a conference that thrives on cross-border dialogue, Lisbon serves as a natural bridge between continents.

A Strong and Vibrant Academic Ecosystem

Portugal has invested heavily in building a high-performing educational and research system. Its universities and research institutes are consistently well-regarded, producing world-class scientific talent and cutting-edge discoveries. For biotech leaders, this means a local ecosystem rich in expertise, prepared to support the full spectrum of innovation, from research and discovery to translational science and commercialization.

Rapid Growth in Biotechnology Innovation

The Portuguese biotech sector is entering an exciting phase of expansion. New companies are launching, research pipelines are maturing, and infrastructure designed specifically for biotechnology is flourishing. Portugal now boasts the full chain of capabilities needed for biotech development, including discovery science, preclinical work, clinical trials, and pathways to market. This evolution positions Lisbon as a showcase for the kind of forward-looking innovation that LSX World Congress champions.

A Collaborative, Global-Minded Talent Base

One of Portugal’s greatest assets is its people. The country’s scientific and business communities are known for being open, collaborative, and internationally oriented. This cultural mindset makes Lisbon an ideal environment for forging new global partnerships, a key objective for any biotech conference. Attendees will find a talent pool eager to connect, share knowledge, and build long-term alliances.

A Country Ready to Reveal Its Biotech Story

Portugal has long been recognized for its beauty, culture, and hospitality, but its biotech capabilities are only now beginning to receive the global attention they deserve. Hosting LSX World Congress in Lisbon provides delegates with the opportunity to discover a thriving ecosystem that blends scientific rigor with an entrepreneurial spirit. This is a moment of visibility for Portugal, a chance for the rest of the world to see the innovation that has been building behind the scenes.

Lisbon embodies exactly what the biotech world looks for in a global gathering point: strategic access to international markets, a strong scientific foundation, a rapidly growing biotech industry, and a collaborative mindset that fuels partnership and progress. As LSX World Congress brings together leaders shaping the future of life sciences, Lisbon offers not just a place to meet, but a platform for new breakthroughs and global connections.